Global Biologics And Biosimilars Industry Market Research Report
Based on the Biologics And Biosimilars industrial chain, this report mainly elaborate the definition, types, applications and major players of Biologics And Biosimilars market in details. Deep analysis about market status (2012-2017), enterprise competition pattern, advantages and disadvantages of enterprise Products, industry development trends (2017-2022), regional industrial layout characteristics and macroeconomic policies, industrial policy has also be included. From raw materials to downstream buyers of this industry will be analyzed scientifically, the feature of product circulation and sales channel will be presented as well. In a word, this report will help you to establish a panorama of industrial development and characteristics of the Biologics And Biosimilars market.
The Biologics And Biosimilars market can be split based on product types, major applications, and important regions.
Major Players in Biologics And Biosimilars market are:
Novo Nordisk
Johnson & Johnson
Amgen
AbbVie
Eli Lilly
United Laboratories
Ganlee
Innovent
Novartis
Biotech
CP Guojian
Dong Bao
Changchun High Tech
Sanofi-Aventis
Pfizer
Roche
Merck
3sbio
Gelgen
Major Regions play vital role in Biologics And Biosimilars market are:
North America
Europe
China
Japan
Middle East & Africa
India
South America
Others
Most important types of Biologics And Biosimilars products covered in this report are:
Growth Factors
Hormone
Antibody
Most widely used downstream fields of Biologics And Biosimilars market covered in this report are:
Cardiovascular
Diabetes
Tumor
The Biologics And Biosimilars market can be split based on product types, major applications, and important regions.
Major Players in Biologics And Biosimilars market are:
Novo Nordisk
Johnson & Johnson
Amgen
AbbVie
Eli Lilly
United Laboratories
Ganlee
Innovent
Novartis
Biotech
CP Guojian
Dong Bao
Changchun High Tech
Sanofi-Aventis
Pfizer
Roche
Merck
3sbio
Gelgen
Major Regions play vital role in Biologics And Biosimilars market are:
North America
Europe
China
Japan
Middle East & Africa
India
South America
Others
Most important types of Biologics And Biosimilars products covered in this report are:
Growth Factors
Hormone
Antibody
Most widely used downstream fields of Biologics And Biosimilars market covered in this report are:
Cardiovascular
Diabetes
Tumor
1 BIOLOGICS AND BIOSIMILARS INTRODUCTION AND MARKET OVERVIEW
1.1 Objectives of the Study
1.2 Definition of Biologics And Biosimilars
1.3 Biologics And Biosimilars Market Scope and Market Size Estimation
1.3.1 Market Concentration Ratio and Market Maturity Analysis
1.3.2 Global Biologics And Biosimilars Value ($) and Growth Rate from 2012-2022
1.4 Market Segmentation
1.4.1 Types of Biologics And Biosimilars
1.4.2 Applications of Biologics And Biosimilars
1.4.3 Research Regions
1.4.3.1 North America Biologics And Biosimilars Production Value ($) and Growth Rate (2012-2017)
1.4.3.2 Europe Biologics And Biosimilars Production Value ($) and Growth Rate (2012-2017)
1.4.3.3 China Biologics And Biosimilars Production Value ($) and Growth Rate (2012-2017)
1.4.3.4 Japan Biologics And Biosimilars Production Value ($) and Growth Rate (2012-2017)
1.4.3.5 Middle East & Africa Biologics And Biosimilars Production Value ($) and Growth Rate (2012-2017)
1.4.3.6 India Biologics And Biosimilars Production Value ($) and Growth Rate (2012-2017)
1.4.3.7 South America Biologics And Biosimilars Production Value ($) and Growth Rate (2012-2017)
1.5 Market Dynamics
1.5.1 Drivers
1.5.1.1 Emerging Countries of Biologics And Biosimilars
1.5.1.2 Growing Market of Biologics And Biosimilars
1.5.2 Limitations
1.5.3 Opportunities
1.6 Industry News and Policies by Regions
1.6.1 Industry News
1.6.2 Industry Policies
2 INDUSTRY CHAIN ANALYSIS
2.1 Upstream Raw Material Suppliers of Biologics And Biosimilars Analysis
2.2 Major Players of Biologics And Biosimilars
2.2.1 Major Players Manufacturing Base and Market Share of Biologics And Biosimilars in 2016
2.2.2 Major Players Product Types in 2016
2.3 Biologics And Biosimilars Manufacturing Cost Structure Analysis
2.3.1 Production Process Analysis
2.3.2 Manufacturing Cost Structure of Biologics And Biosimilars
2.3.3 Raw Material Cost of Biologics And Biosimilars
2.3.4 Labor Cost of Biologics And Biosimilars
2.4 Market Channel Analysis of Biologics And Biosimilars
2.5 Major Downstream Buyers of Biologics And Biosimilars Analysis
3 GLOBAL BIOLOGICS AND BIOSIMILARS MARKET, BY TYPE
3.1 Analysis of Market Status and Feature by Type
3.2 Global Biologics And Biosimilars Value ($) and Market Share by Type (2012-2017)
3.3 Global Biologics And Biosimilars Production and Market Share by Type (2012-2017)
3.4 Global Biologics And Biosimilars Value ($) and Growth Rate by Type (2012-2017)
3.5 Global Biologics And Biosimilars Price Analysis by Type (2012-2017)
4 BIOLOGICS AND BIOSIMILARS MARKET, BY APPLICATION
4.1 Downstream Market Overview
4.2 Global Biologics And Biosimilars Consumption and Market Share by Application (2012-2017)
4.3 Downstream Buyers by Application
4.4 Global Biologics And Biosimilars Consumption and Growth Rate by Application (2012-2017)
5 GLOBAL BIOLOGICS AND BIOSIMILARS PRODUCTION, VALUE ($) BY REGION (2012-2017)
5.1 Global Biologics And Biosimilars Value ($) and Market Share by Region (2012-2017)
5.2 Global Biologics And Biosimilars Production and Market Share by Region (2012-2017)
5.3 Global Biologics And Biosimilars Production, Value ($), Price and Gross Margin (2012-2017)
5.4 North America Biologics And Biosimilars Production, Value ($), Price and Gross Margin (2012-2017)
5.5 Europe Biologics And Biosimilars Production, Value ($), Price and Gross Margin (2012-2017)
5.6 China Biologics And Biosimilars Production, Value ($), Price and Gross Margin (2012-2017)
5.7 Japan Biologics And Biosimilars Production, Value ($), Price and Gross Margin (2012-2017)
5.8 Middle East & Africa Biologics And Biosimilars Production, Value ($), Price and Gross Margin (2012-2017)
5.9 India Biologics And Biosimilars Production, Value ($), Price and Gross Margin (2012-2017)
5.10 South America Biologics And Biosimilars Production, Value ($), Price and Gross Margin (2012-2017)
6 GLOBAL BIOLOGICS AND BIOSIMILARS PRODUCTION, CONSUMPTION, EXPORT, IMPORT BY REGIONS (2012-2017)
6.1 Global Biologics And Biosimilars Consumption by Regions (2012-2017)
6.2 North America Biologics And Biosimilars Production, Consumption, Export, Import (2012-2017)
6.3 Europe Biologics And Biosimilars Production, Consumption, Export, Import (2012-2017)
6.4 China Biologics And Biosimilars Production, Consumption, Export, Import (2012-2017)
6.5 Japan Biologics And Biosimilars Production, Consumption, Export, Import (2012-2017)
6.6 Middle East & Africa Biologics And Biosimilars Production, Consumption, Export, Import (2012-2017)
6.7 India Biologics And Biosimilars Production, Consumption, Export, Import (2012-2017)
6.8 South America Biologics And Biosimilars Production, Consumption, Export, Import (2012-2017)
7 GLOBAL BIOLOGICS AND BIOSIMILARS MARKET STATUS AND SWOT ANALYSIS BY REGIONS
7.1 North America Biologics And Biosimilars Market Status and SWOT Analysis
7.2 Europe Biologics And Biosimilars Market Status and SWOT Analysis
7.3 China Biologics And Biosimilars Market Status and SWOT Analysis
7.4 Japan Biologics And Biosimilars Market Status and SWOT Analysis
7.5 Middle East & Africa Biologics And Biosimilars Market Status and SWOT Analysis
7.6 India Biologics And Biosimilars Market Status and SWOT Analysis
7.7 South America Biologics And Biosimilars Market Status and SWOT Analysis
8 COMPETITIVE LANDSCAPE
8.1 Competitive Profile
8.2 Novo Nordisk
8.2.1 Company Profiles
8.2.2 Biologics And Biosimilars Product Introduction and Market Positioning
8.2.2.1 Product Introduction
8.2.2.2 Market Positioning and Target Customers
8.2.3 Novo Nordisk Production, Value ($), Price, Gross Margin 2012-2017E
8.2.4 Novo Nordisk Market Share of Biologics And Biosimilars Segmented by Region in 2016
8.3 Johnson & Johnson
8.3.1 Company Profiles
8.3.2 Biologics And Biosimilars Product Introduction and Market Positioning
8.3.2.1 Product Introduction
8.3.2.2 Market Positioning and Target Customers
8.3.3 Johnson & Johnson Production, Value ($), Price, Gross Margin 2012-2017E
8.3.4 Johnson & Johnson Market Share of Biologics And Biosimilars Segmented by Region in 2016
8.4 Amgen
8.4.1 Company Profiles
8.4.2 Biologics And Biosimilars Product Introduction and Market Positioning
8.4.2.1 Product Introduction
8.4.2.2 Market Positioning and Target Customers
8.4.3 Amgen Production, Value ($), Price, Gross Margin 2012-2017E
8.4.4 Amgen Market Share of Biologics And Biosimilars Segmented by Region in 2016
8.5 AbbVie
8.5.1 Company Profiles
8.5.2 Biologics And Biosimilars Product Introduction and Market Positioning
8.5.2.1 Product Introduction
8.5.2.2 Market Positioning and Target Customers
8.5.3 AbbVie Production, Value ($), Price, Gross Margin 2012-2017E
8.5.4 AbbVie Market Share of Biologics And Biosimilars Segmented by Region in 2016
8.6 Eli Lilly
8.6.1 Company Profiles
8.6.2 Biologics And Biosimilars Product Introduction and Market Positioning
8.6.2.1 Product Introduction
8.6.2.2 Market Positioning and Target Customers
8.6.3 Eli Lilly Production, Value ($), Price, Gross Margin 2012-2017E
8.6.4 Eli Lilly Market Share of Biologics And Biosimilars Segmented by Region in 2016
8.7 United Laboratories
8.7.1 Company Profiles
8.7.2 Biologics And Biosimilars Product Introduction and Market Positioning
8.7.2.1 Product Introduction
8.7.2.2 Market Positioning and Target Customers
8.7.3 United Laboratories Production, Value ($), Price, Gross Margin 2012-2017E
8.7.4 United Laboratories Market Share of Biologics And Biosimilars Segmented by Region in 2016
8.8 Ganlee
8.8.1 Company Profiles
8.8.2 Biologics And Biosimilars Product Introduction and Market Positioning
8.8.2.1 Product Introduction
8.8.2.2 Market Positioning and Target Customers
8.8.3 Ganlee Production, Value ($), Price, Gross Margin 2012-2017E
8.8.4 Ganlee Market Share of Biologics And Biosimilars Segmented by Region in 2016
8.9 Innovent
8.9.1 Company Profiles
8.9.2 Biologics And Biosimilars Product Introduction and Market Positioning
8.9.2.1 Product Introduction
8.9.2.2 Market Positioning and Target Customers
8.9.3 Innovent Production, Value ($), Price, Gross Margin 2012-2017E
8.9.4 Innovent Market Share of Biologics And Biosimilars Segmented by Region in 2016
8.10 Novartis
8.10.1 Company Profiles
8.10.2 Biologics And Biosimilars Product Introduction and Market Positioning
8.10.2.1 Product Introduction
8.10.2.2 Market Positioning and Target Customers
8.10.3 Novartis Production, Value ($), Price, Gross Margin 2012-2017E
8.10.4 Novartis Market Share of Biologics And Biosimilars Segmented by Region in 2016
8.11 Biotech
8.11.1 Company Profiles
8.11.2 Biologics And Biosimilars Product Introduction and Market Positioning
8.11.2.1 Product Introduction
8.11.2.2 Market Positioning and Target Customers
8.11.3 Biotech Production, Value ($), Price, Gross Margin 2012-2017E
8.11.4 Biotech Market Share of Biologics And Biosimilars Segmented by Region in 2016
8.12 CP Guojian
8.12.1 Company Profiles
8.12.2 Biologics And Biosimilars Product Introduction and Market Positioning
8.12.2.1 Product Introduction
8.12.2.2 Market Positioning and Target Customers
8.12.3 CP Guojian Production, Value ($), Price, Gross Margin 2012-2017E
8.12.4 CP Guojian Market Share of Biologics And Biosimilars Segmented by Region in 2016
8.13 Dong Bao
8.13.1 Company Profiles
8.13.2 Biologics And Biosimilars Product Introduction and Market Positioning
8.13.2.1 Product Introduction
8.13.2.2 Market Positioning and Target Customers
8.13.3 Dong Bao Production, Value ($), Price, Gross Margin 2012-2017E
8.13.4 Dong Bao Market Share of Biologics And Biosimilars Segmented by Region in 2016
8.14 Changchun High Tech
8.14.1 Company Profiles
8.14.2 Biologics And Biosimilars Product Introduction and Market Positioning
8.14.2.1 Product Introduction
8.14.2.2 Market Positioning and Target Customers
8.14.3 Changchun High Tech Production, Value ($), Price, Gross Margin 2012-2017E
8.14.4 Changchun High Tech Market Share of Biologics And Biosimilars Segmented by Region in 2016
8.15 Sanofi-Aventis
8.15.1 Company Profiles
8.15.2 Biologics And Biosimilars Product Introduction and Market Positioning
8.15.2.1 Product Introduction
8.15.2.2 Market Positioning and Target Customers
8.15.3 Sanofi-Aventis Production, Value ($), Price, Gross Margin 2012-2017E
8.15.4 Sanofi-Aventis Market Share of Biologics And Biosimilars Segmented by Region in 2016
8.16 Pfizer
8.16.1 Company Profiles
8.16.2 Biologics And Biosimilars Product Introduction and Market Positioning
8.16.2.1 Product Introduction
8.16.2.2 Market Positioning and Target Customers
8.16.3 Pfizer Production, Value ($), Price, Gross Margin 2012-2017E
8.16.4 Pfizer Market Share of Biologics And Biosimilars Segmented by Region in 2016
8.17 Roche
8.18 Merck
8.19 3sbio
8.20 Gelgen
9 GLOBAL BIOLOGICS AND BIOSIMILARS MARKET ANALYSIS AND FORECAST BY TYPE AND APPLICATION
9.1 Global Biologics And Biosimilars Market Value ($) & Volume Forecast, by Type (2017-2022)
9.1.1 Growth Factors Market Value ($) and Volume Forecast (2017-2022)
9.1.2 Hormone Market Value ($) and Volume Forecast (2017-2022)
9.1.3 Antibody Market Value ($) and Volume Forecast (2017-2022)
9.2 Global Biologics And Biosimilars Market Value ($) & Volume Forecast, by Application (2017-2022)
9.2.1 Cardiovascular Market Value ($) and Volume Forecast (2017-2022)
9.2.2 Diabetes Market Value ($) and Volume Forecast (2017-2022)
9.2.3 Tumor Market Value ($) and Volume Forecast (2017-2022)
10 BIOLOGICS AND BIOSIMILARS MARKET ANALYSIS AND FORECAST BY REGION
10.1 North America Market Value ($) and Consumption Forecast (2017-2022)
10.2 Europe Market Value ($) and Consumption Forecast (2017-2022)
10.3 China Market Value ($) and Consumption Forecast (2017-2022)
10.4 Japan Market Value ($) and Consumption Forecast (2017-2022)
10.5 Middle East & Africa Market Value ($) and Consumption Forecast (2017-2022)
10.6 India Market Value ($) and Consumption Forecast (2017-2022)
10.7 South America Market Value ($) and Consumption Forecast (2017-2022)
11 NEW PROJECT FEASIBILITY ANALYSIS
11.1 Industry Barriers and New Entrants SWOT Analysis
11.2 Analysis and Suggestions on New Project Investment
12 RESEARCH FINDING AND CONCLUSION
13 APPENDIX
13.1 Discussion Guide
13.2 Knowledge Store: Maia Subscription Portal
13.3 Research Data Source
13.4 Research Assumptions and Acronyms Used
1.1 Objectives of the Study
1.2 Definition of Biologics And Biosimilars
1.3 Biologics And Biosimilars Market Scope and Market Size Estimation
1.3.1 Market Concentration Ratio and Market Maturity Analysis
1.3.2 Global Biologics And Biosimilars Value ($) and Growth Rate from 2012-2022
1.4 Market Segmentation
1.4.1 Types of Biologics And Biosimilars
1.4.2 Applications of Biologics And Biosimilars
1.4.3 Research Regions
1.4.3.1 North America Biologics And Biosimilars Production Value ($) and Growth Rate (2012-2017)
1.4.3.2 Europe Biologics And Biosimilars Production Value ($) and Growth Rate (2012-2017)
1.4.3.3 China Biologics And Biosimilars Production Value ($) and Growth Rate (2012-2017)
1.4.3.4 Japan Biologics And Biosimilars Production Value ($) and Growth Rate (2012-2017)
1.4.3.5 Middle East & Africa Biologics And Biosimilars Production Value ($) and Growth Rate (2012-2017)
1.4.3.6 India Biologics And Biosimilars Production Value ($) and Growth Rate (2012-2017)
1.4.3.7 South America Biologics And Biosimilars Production Value ($) and Growth Rate (2012-2017)
1.5 Market Dynamics
1.5.1 Drivers
1.5.1.1 Emerging Countries of Biologics And Biosimilars
1.5.1.2 Growing Market of Biologics And Biosimilars
1.5.2 Limitations
1.5.3 Opportunities
1.6 Industry News and Policies by Regions
1.6.1 Industry News
1.6.2 Industry Policies
2 INDUSTRY CHAIN ANALYSIS
2.1 Upstream Raw Material Suppliers of Biologics And Biosimilars Analysis
2.2 Major Players of Biologics And Biosimilars
2.2.1 Major Players Manufacturing Base and Market Share of Biologics And Biosimilars in 2016
2.2.2 Major Players Product Types in 2016
2.3 Biologics And Biosimilars Manufacturing Cost Structure Analysis
2.3.1 Production Process Analysis
2.3.2 Manufacturing Cost Structure of Biologics And Biosimilars
2.3.3 Raw Material Cost of Biologics And Biosimilars
2.3.4 Labor Cost of Biologics And Biosimilars
2.4 Market Channel Analysis of Biologics And Biosimilars
2.5 Major Downstream Buyers of Biologics And Biosimilars Analysis
3 GLOBAL BIOLOGICS AND BIOSIMILARS MARKET, BY TYPE
3.1 Analysis of Market Status and Feature by Type
3.2 Global Biologics And Biosimilars Value ($) and Market Share by Type (2012-2017)
3.3 Global Biologics And Biosimilars Production and Market Share by Type (2012-2017)
3.4 Global Biologics And Biosimilars Value ($) and Growth Rate by Type (2012-2017)
3.5 Global Biologics And Biosimilars Price Analysis by Type (2012-2017)
4 BIOLOGICS AND BIOSIMILARS MARKET, BY APPLICATION
4.1 Downstream Market Overview
4.2 Global Biologics And Biosimilars Consumption and Market Share by Application (2012-2017)
4.3 Downstream Buyers by Application
4.4 Global Biologics And Biosimilars Consumption and Growth Rate by Application (2012-2017)
5 GLOBAL BIOLOGICS AND BIOSIMILARS PRODUCTION, VALUE ($) BY REGION (2012-2017)
5.1 Global Biologics And Biosimilars Value ($) and Market Share by Region (2012-2017)
5.2 Global Biologics And Biosimilars Production and Market Share by Region (2012-2017)
5.3 Global Biologics And Biosimilars Production, Value ($), Price and Gross Margin (2012-2017)
5.4 North America Biologics And Biosimilars Production, Value ($), Price and Gross Margin (2012-2017)
5.5 Europe Biologics And Biosimilars Production, Value ($), Price and Gross Margin (2012-2017)
5.6 China Biologics And Biosimilars Production, Value ($), Price and Gross Margin (2012-2017)
5.7 Japan Biologics And Biosimilars Production, Value ($), Price and Gross Margin (2012-2017)
5.8 Middle East & Africa Biologics And Biosimilars Production, Value ($), Price and Gross Margin (2012-2017)
5.9 India Biologics And Biosimilars Production, Value ($), Price and Gross Margin (2012-2017)
5.10 South America Biologics And Biosimilars Production, Value ($), Price and Gross Margin (2012-2017)
6 GLOBAL BIOLOGICS AND BIOSIMILARS PRODUCTION, CONSUMPTION, EXPORT, IMPORT BY REGIONS (2012-2017)
6.1 Global Biologics And Biosimilars Consumption by Regions (2012-2017)
6.2 North America Biologics And Biosimilars Production, Consumption, Export, Import (2012-2017)
6.3 Europe Biologics And Biosimilars Production, Consumption, Export, Import (2012-2017)
6.4 China Biologics And Biosimilars Production, Consumption, Export, Import (2012-2017)
6.5 Japan Biologics And Biosimilars Production, Consumption, Export, Import (2012-2017)
6.6 Middle East & Africa Biologics And Biosimilars Production, Consumption, Export, Import (2012-2017)
6.7 India Biologics And Biosimilars Production, Consumption, Export, Import (2012-2017)
6.8 South America Biologics And Biosimilars Production, Consumption, Export, Import (2012-2017)
7 GLOBAL BIOLOGICS AND BIOSIMILARS MARKET STATUS AND SWOT ANALYSIS BY REGIONS
7.1 North America Biologics And Biosimilars Market Status and SWOT Analysis
7.2 Europe Biologics And Biosimilars Market Status and SWOT Analysis
7.3 China Biologics And Biosimilars Market Status and SWOT Analysis
7.4 Japan Biologics And Biosimilars Market Status and SWOT Analysis
7.5 Middle East & Africa Biologics And Biosimilars Market Status and SWOT Analysis
7.6 India Biologics And Biosimilars Market Status and SWOT Analysis
7.7 South America Biologics And Biosimilars Market Status and SWOT Analysis
8 COMPETITIVE LANDSCAPE
8.1 Competitive Profile
8.2 Novo Nordisk
8.2.1 Company Profiles
8.2.2 Biologics And Biosimilars Product Introduction and Market Positioning
8.2.2.1 Product Introduction
8.2.2.2 Market Positioning and Target Customers
8.2.3 Novo Nordisk Production, Value ($), Price, Gross Margin 2012-2017E
8.2.4 Novo Nordisk Market Share of Biologics And Biosimilars Segmented by Region in 2016
8.3 Johnson & Johnson
8.3.1 Company Profiles
8.3.2 Biologics And Biosimilars Product Introduction and Market Positioning
8.3.2.1 Product Introduction
8.3.2.2 Market Positioning and Target Customers
8.3.3 Johnson & Johnson Production, Value ($), Price, Gross Margin 2012-2017E
8.3.4 Johnson & Johnson Market Share of Biologics And Biosimilars Segmented by Region in 2016
8.4 Amgen
8.4.1 Company Profiles
8.4.2 Biologics And Biosimilars Product Introduction and Market Positioning
8.4.2.1 Product Introduction
8.4.2.2 Market Positioning and Target Customers
8.4.3 Amgen Production, Value ($), Price, Gross Margin 2012-2017E
8.4.4 Amgen Market Share of Biologics And Biosimilars Segmented by Region in 2016
8.5 AbbVie
8.5.1 Company Profiles
8.5.2 Biologics And Biosimilars Product Introduction and Market Positioning
8.5.2.1 Product Introduction
8.5.2.2 Market Positioning and Target Customers
8.5.3 AbbVie Production, Value ($), Price, Gross Margin 2012-2017E
8.5.4 AbbVie Market Share of Biologics And Biosimilars Segmented by Region in 2016
8.6 Eli Lilly
8.6.1 Company Profiles
8.6.2 Biologics And Biosimilars Product Introduction and Market Positioning
8.6.2.1 Product Introduction
8.6.2.2 Market Positioning and Target Customers
8.6.3 Eli Lilly Production, Value ($), Price, Gross Margin 2012-2017E
8.6.4 Eli Lilly Market Share of Biologics And Biosimilars Segmented by Region in 2016
8.7 United Laboratories
8.7.1 Company Profiles
8.7.2 Biologics And Biosimilars Product Introduction and Market Positioning
8.7.2.1 Product Introduction
8.7.2.2 Market Positioning and Target Customers
8.7.3 United Laboratories Production, Value ($), Price, Gross Margin 2012-2017E
8.7.4 United Laboratories Market Share of Biologics And Biosimilars Segmented by Region in 2016
8.8 Ganlee
8.8.1 Company Profiles
8.8.2 Biologics And Biosimilars Product Introduction and Market Positioning
8.8.2.1 Product Introduction
8.8.2.2 Market Positioning and Target Customers
8.8.3 Ganlee Production, Value ($), Price, Gross Margin 2012-2017E
8.8.4 Ganlee Market Share of Biologics And Biosimilars Segmented by Region in 2016
8.9 Innovent
8.9.1 Company Profiles
8.9.2 Biologics And Biosimilars Product Introduction and Market Positioning
8.9.2.1 Product Introduction
8.9.2.2 Market Positioning and Target Customers
8.9.3 Innovent Production, Value ($), Price, Gross Margin 2012-2017E
8.9.4 Innovent Market Share of Biologics And Biosimilars Segmented by Region in 2016
8.10 Novartis
8.10.1 Company Profiles
8.10.2 Biologics And Biosimilars Product Introduction and Market Positioning
8.10.2.1 Product Introduction
8.10.2.2 Market Positioning and Target Customers
8.10.3 Novartis Production, Value ($), Price, Gross Margin 2012-2017E
8.10.4 Novartis Market Share of Biologics And Biosimilars Segmented by Region in 2016
8.11 Biotech
8.11.1 Company Profiles
8.11.2 Biologics And Biosimilars Product Introduction and Market Positioning
8.11.2.1 Product Introduction
8.11.2.2 Market Positioning and Target Customers
8.11.3 Biotech Production, Value ($), Price, Gross Margin 2012-2017E
8.11.4 Biotech Market Share of Biologics And Biosimilars Segmented by Region in 2016
8.12 CP Guojian
8.12.1 Company Profiles
8.12.2 Biologics And Biosimilars Product Introduction and Market Positioning
8.12.2.1 Product Introduction
8.12.2.2 Market Positioning and Target Customers
8.12.3 CP Guojian Production, Value ($), Price, Gross Margin 2012-2017E
8.12.4 CP Guojian Market Share of Biologics And Biosimilars Segmented by Region in 2016
8.13 Dong Bao
8.13.1 Company Profiles
8.13.2 Biologics And Biosimilars Product Introduction and Market Positioning
8.13.2.1 Product Introduction
8.13.2.2 Market Positioning and Target Customers
8.13.3 Dong Bao Production, Value ($), Price, Gross Margin 2012-2017E
8.13.4 Dong Bao Market Share of Biologics And Biosimilars Segmented by Region in 2016
8.14 Changchun High Tech
8.14.1 Company Profiles
8.14.2 Biologics And Biosimilars Product Introduction and Market Positioning
8.14.2.1 Product Introduction
8.14.2.2 Market Positioning and Target Customers
8.14.3 Changchun High Tech Production, Value ($), Price, Gross Margin 2012-2017E
8.14.4 Changchun High Tech Market Share of Biologics And Biosimilars Segmented by Region in 2016
8.15 Sanofi-Aventis
8.15.1 Company Profiles
8.15.2 Biologics And Biosimilars Product Introduction and Market Positioning
8.15.2.1 Product Introduction
8.15.2.2 Market Positioning and Target Customers
8.15.3 Sanofi-Aventis Production, Value ($), Price, Gross Margin 2012-2017E
8.15.4 Sanofi-Aventis Market Share of Biologics And Biosimilars Segmented by Region in 2016
8.16 Pfizer
8.16.1 Company Profiles
8.16.2 Biologics And Biosimilars Product Introduction and Market Positioning
8.16.2.1 Product Introduction
8.16.2.2 Market Positioning and Target Customers
8.16.3 Pfizer Production, Value ($), Price, Gross Margin 2012-2017E
8.16.4 Pfizer Market Share of Biologics And Biosimilars Segmented by Region in 2016
8.17 Roche
8.18 Merck
8.19 3sbio
8.20 Gelgen
9 GLOBAL BIOLOGICS AND BIOSIMILARS MARKET ANALYSIS AND FORECAST BY TYPE AND APPLICATION
9.1 Global Biologics And Biosimilars Market Value ($) & Volume Forecast, by Type (2017-2022)
9.1.1 Growth Factors Market Value ($) and Volume Forecast (2017-2022)
9.1.2 Hormone Market Value ($) and Volume Forecast (2017-2022)
9.1.3 Antibody Market Value ($) and Volume Forecast (2017-2022)
9.2 Global Biologics And Biosimilars Market Value ($) & Volume Forecast, by Application (2017-2022)
9.2.1 Cardiovascular Market Value ($) and Volume Forecast (2017-2022)
9.2.2 Diabetes Market Value ($) and Volume Forecast (2017-2022)
9.2.3 Tumor Market Value ($) and Volume Forecast (2017-2022)
10 BIOLOGICS AND BIOSIMILARS MARKET ANALYSIS AND FORECAST BY REGION
10.1 North America Market Value ($) and Consumption Forecast (2017-2022)
10.2 Europe Market Value ($) and Consumption Forecast (2017-2022)
10.3 China Market Value ($) and Consumption Forecast (2017-2022)
10.4 Japan Market Value ($) and Consumption Forecast (2017-2022)
10.5 Middle East & Africa Market Value ($) and Consumption Forecast (2017-2022)
10.6 India Market Value ($) and Consumption Forecast (2017-2022)
10.7 South America Market Value ($) and Consumption Forecast (2017-2022)
11 NEW PROJECT FEASIBILITY ANALYSIS
11.1 Industry Barriers and New Entrants SWOT Analysis
11.2 Analysis and Suggestions on New Project Investment
12 RESEARCH FINDING AND CONCLUSION
13 APPENDIX
13.1 Discussion Guide
13.2 Knowledge Store: Maia Subscription Portal
13.3 Research Data Source
13.4 Research Assumptions and Acronyms Used
LIST OF TABLES AND FIGURES
Figure Product Picture of Biologics And Biosimilars
Table Product Specification of Biologics And Biosimilars
Figure Market Concentration Ratio and Market Maturity Analysis of Biologics And Biosimilars
Figure Global Biologics And Biosimilars Value ($) and Growth Rate from 2012-2022
Table Different Types of Biologics And Biosimilars
Figure Global Biologics And Biosimilars Value ($) Segment by Type from 2012-2017
Figure Growth Factors Picture
Figure Hormone Picture
Figure Antibody Picture
Table Different Applications of Biologics And Biosimilars
Figure Global Biologics And Biosimilars Value ($) Segment by Applications from 2012-2017
Figure Cardiovascular Picture
Figure Diabetes Picture
Figure Tumor Picture
Table Research Regions of Biologics And Biosimilars
Figure North America Biologics And Biosimilars Production Value ($) and Growth Rate (2012-2017)
Figure Europe Biologics And Biosimilars Production Value ($) and Growth Rate (2012-2017)
Table China Biologics And Biosimilars Production Value ($) and Growth Rate (2012-2017)
Table Japan Biologics And Biosimilars Production Value ($) and Growth Rate (2012-2017)
Table Middle East & Africa Biologics And Biosimilars Production Value ($) and Growth Rate (2012-2017)
Table India Biologics And Biosimilars Production Value ($) and Growth Rate (2012-2017)
Table South America Biologics And Biosimilars Production Value ($) and Growth Rate (2012-2017)
Table Emerging Countries of Biologics And Biosimilars
Table Growing Market of Biologics And Biosimilars
Figure Industry Chain Analysis of Biologics And Biosimilars
Table Upstream Raw Material Suppliers of Biologics And Biosimilars with Contact Information
Table Major Players Manufacturing Base and Market Share ($) of Biologics And Biosimilars in 2016
Table Major Players Biologics And Biosimilars Product Types in 2016
Figure Production Process of Biologics And Biosimilars
Figure Manufacturing Cost Structure of Biologics And Biosimilars
Figure Channel Status of Biologics And Biosimilars
Table Major Distributors of Biologics And Biosimilars with Contact Information
Table Major Downstream Buyers of Biologics And Biosimilars with Contact Information
Table Analysis of Market Status and Feature by Type
Table Global Biologics And Biosimilars Value ($) by Type (2012-2017)
Table Global Biologics And Biosimilars Value ($) Share by Type (2012-2017)
Figure Global Biologics And Biosimilars Value ($) Share by Type (2012-2017)
Table Global Biologics And Biosimilars Production by Type (2012-2017)
Table Global Biologics And Biosimilars Production Share by Type (2012-2017)
Figure Global Biologics And Biosimilars Production Share by Type (2012-2017)
Figure Global Biologics And Biosimilars Value ($) and Growth Rate of Growth Factors
Figure Global Biologics And Biosimilars Value ($) and Growth Rate of Hormone
Figure Global Biologics And Biosimilars Value ($) and Growth Rate of Antibody
Table Global Biologics And Biosimilars Price by Type (2012-2017)
Figure Downstream Market Overview
Table Global Biologics And Biosimilars Consumption by Application (2012-2017)
Table Global Biologics And Biosimilars Consumption Market Share by Application (2012-2017)
Figure Global Biologics And Biosimilars Consumption Market Share by Application (2012-2017)
Table Downstream Buyers Introduction by Application
Figure Global Biologics And Biosimilars Consumption and Growth Rate of Cardiovascular (2012-2017)
Figure Global Biologics And Biosimilars Consumption and Growth Rate of Diabetes (2012-2017)
Figure Global Biologics And Biosimilars Consumption and Growth Rate of Tumor (2012-2017)
Table Global Biologics And Biosimilars Value ($) by Region (2012-2017)
Table Global Biologics And Biosimilars Value ($) Market Share by Region (2012-2017)
Figure Global Biologics And Biosimilars Value ($) Market Share by Region (2012-2017)
Table Global Biologics And Biosimilars Production by Region (2012-2017)
Table Global Biologics And Biosimilars Production Market Share by Region (2012-2017)
Figure Global Biologics And Biosimilars Production Market Share by Region (2012-2017)
Table Global Biologics And Biosimilars Production, Value ($), Price and Gross Margin (2012-2017)
Table North America Biologics And Biosimilars Production, Value ($), Price and Gross Margin (2012-2017)
Table Europe Biologics And Biosimilars Production, Value ($), Price and Gross Margin (2012-2017)
Table China Biologics And Biosimilars Production, Value ($), Price and Gross Margin (2012-2017)
Table Japan Biologics And Biosimilars Production, Value ($), Price and Gross Margin (2012-2017)
Table Middle East & Africa Biologics And Biosimilars Production, Value ($), Price and Gross Margin (2012-2017)
Table India Biologics And Biosimilars Production, Value ($), Price and Gross Margin (2012-2017)
Table South America Biologics And Biosimilars Production, Value ($), Price and Gross Margin (2012-2017)
Table Global Biologics And Biosimilars Consumption by Regions (2012-2017)
Figure Global Biologics And Biosimilars Consumption Share by Regions (2012-2017)
Table North America Biologics And Biosimilars Production, Consumption, Export, Import (2012-2017)
Table Europe Biologics And Biosimilars Production, Consumption, Export, Import (2012-2017)
Table China Biologics And Biosimilars Production, Consumption, Export, Import (2012-2017)
Table Japan Biologics And Biosimilars Production, Consumption, Export, Import (2012-2017)
Table Middle East & Africa Biologics And Biosimilars Production, Consumption, Export, Import (2012-2017)
Table India Biologics And Biosimilars Production, Consumption, Export, Import (2012-2017)
Table South America Biologics And Biosimilars Production, Consumption, Export, Import (2012-2017)
Figure North America Biologics And Biosimilars Production and Growth Rate Analysis
Figure North America Biologics And Biosimilars Consumption and Growth Rate Analysis
Figure North America Biologics And Biosimilars SWOT Analysis
Figure Europe Biologics And Biosimilars Production and Growth Rate Analysis
Figure Europe Biologics And Biosimilars Consumption and Growth Rate Analysis
Figure Europe Biologics And Biosimilars SWOT Analysis
Figure China Biologics And Biosimilars Production and Growth Rate Analysis
Figure China Biologics And Biosimilars Consumption and Growth Rate Analysis
Figure China Biologics And Biosimilars SWOT Analysis
Figure Japan Biologics And Biosimilars Production and Growth Rate Analysis
Figure Japan Biologics And Biosimilars Consumption and Growth Rate Analysis
Figure Japan Biologics And Biosimilars SWOT Analysis
Figure Middle East & Africa Biologics And Biosimilars Production and Growth Rate Analysis
Figure Middle East & Africa Biologics And Biosimilars Consumption and Growth Rate Analysis
Figure Middle East & Africa Biologics And Biosimilars SWOT Analysis
Figure India Biologics And Biosimilars Production and Growth Rate Analysis
Figure India Biologics And Biosimilars Consumption and Growth Rate Analysis
Figure India Biologics And Biosimilars SWOT Analysis
Figure South America Biologics And Biosimilars Production and Growth Rate Analysis
Figure South America Biologics And Biosimilars Consumption and Growth Rate Analysis
Figure South America Biologics And Biosimilars SWOT Analysis
Figure Competitive Matrix and Pattern Characteristics of Biologics And Biosimilars Market
Figure Top 3 Market Share of Biologics And Biosimilars Companies
Figure Top 6 Market Share of Biologics And Biosimilars Companies
Table Mergers, Acquisitions and Expansion Analysis
Table Company Profiles
Table Product Introduction
Table Market Positioning and Target Customers
Table Novo Nordisk Production, Value ($), Price, Gross Margin 2012-2017E
Figure Novo Nordisk Production and Growth Rate
Figure Novo Nordisk Value ($) Market Share 2012-2017E
Figure Novo Nordisk Market Share of Biologics And Biosimilars Segmented by Region in 2016
Table Company Profiles
Table Product Introduction
Table Market Positioning and Target Customers
Table Johnson & Johnson Production, Value ($), Price, Gross Margin 2012-2017E
Figure Johnson & Johnson Production and Growth Rate
Figure Johnson & Johnson Value ($) Market Share 2012-2017E
Figure Johnson & Johnson Market Share of Biologics And Biosimilars Segmented by Region in 2016
Table Company Profiles
Table Product Introduction
Table Market Positioning and Target Customers
Table Amgen Production, Value ($), Price, Gross Margin 2012-2017E
Figure Amgen Production and Growth Rate
Figure Amgen Value ($) Market Share 2012-2017E
Figure Amgen Market Share of Biologics And Biosimilars Segmented by Region in 2016
Table Company Profiles
Table Product Introduction
Table Market Positioning and Target Customers
Table AbbVie Production, Value ($), Price, Gross Margin 2012-2017E
Figure AbbVie Production and Growth Rate
Figure AbbVie Value ($) Market Share 2012-2017E
Figure AbbVie Market Share of Biologics And Biosimilars Segmented by Region in 2016
Table Company Profiles
Table Product Introduction
Table Market Positioning and Target Customers
Table Eli Lilly Production, Value ($), Price, Gross Margin 2012-2017E
Figure Eli Lilly Production and Growth Rate
Figure Eli Lilly Value ($) Market Share 2012-2017E
Figure Eli Lilly Market Share of Biologics And Biosimilars Segmented by Region in 2016
Table Company Profiles
Table Product Introduction
Table Market Positioning and Target Customers
Table United Laboratories Production, Value ($), Price, Gross Margin 2012-2017E
Figure United Laboratories Production and Growth Rate
Figure United Laboratories Value ($) Market Share 2012-2017E
Figure United Laboratories Market Share of Biologics And Biosimilars Segmented by Region in 2016
Table Company Profiles
Table Product Introduction
Table Market Positioning and Target Customers
Table Ganlee Production, Value ($), Price, Gross Margin 2012-2017E
Figure Ganlee Production and Growth Rate
Figure Ganlee Value ($) Market Share 2012-2017E
Figure Ganlee Market Share of Biologics And Biosimilars Segmented by Region in 2016
Table Company Profiles
Table Product Introduction
Table Market Positioning and Target Customers
Table Innovent Production, Value ($), Price, Gross Margin 2012-2017E
Figure Innovent Production and Growth Rate
Figure Innovent Value ($) Market Share 2012-2017E
Figure Innovent Market Share of Biologics And Biosimilars Segmented by Region in 2016
Table Company Profiles
Table Product Introduction
Table Market Positioning and Target Customers
Table Novartis Production, Value ($), Price, Gross Margin 2012-2017E
Figure Novartis Production and Growth Rate
Figure Novartis Value ($) Market Share 2012-2017E
Figure Novartis Market Share of Biologics And Biosimilars Segmented by Region in 2016
Table Company Profiles
Table Product Introduction
Table Market Positioning and Target Customers
Table Biotech Production, Value ($), Price, Gross Margin 2012-2017E
Figure Biotech Production and Growth Rate
Figure Biotech Value ($) Market Share 2012-2017E
Figure Biotech Market Share of Biologics And Biosimilars Segmented by Region in 2016
Table Company Profiles
Table Product Introduction
Table Market Positioning and Target Customers
Table CP Guojian Production, Value ($), Price, Gross Margin 2012-2017E
Figure CP Guojian Production and Growth Rate
Figure CP Guojian Value ($) Market Share 2012-2017E
Figure CP Guojian Market Share of Biologics And Biosimilars Segmented by Region in 2016
Table Company Profiles
Table Product Introduction
Table Market Positioning and Target Customers
Table Dong Bao Production, Value ($), Price, Gross Margin 2012-2017E
Figure Dong Bao Production and Growth Rate
Figure Dong Bao Value ($) Market Share 2012-2017E
Figure Dong Bao Market Share of Biologics And Biosimilars Segmented by Region in 2016
Table Company Profiles
Table Product Introduction
Table Market Positioning and Target Customers
Table Changchun High Tech Production, Value ($), Price, Gross Margin 2012-2017E
Figure Changchun High Tech Production and Growth Rate
Figure Changchun High Tech Value ($) Market Share 2012-2017E
Figure Changchun High Tech Market Share of Biologics And Biosimilars Segmented by Region in 2016
Table Company Profiles
Table Product Introduction
Table Market Positioning and Target Customers
Table Sanofi-Aventis Production, Value ($), Price, Gross Margin 2012-2017E
Figure Sanofi-Aventis Production and Growth Rate
Figure Sanofi-Aventis Value ($) Market Share 2012-2017E
Figure Sanofi-Aventis Market Share of Biologics And Biosimilars Segmented by Region in 2016
Table Company Profiles
Table Product Introduction
Table Market Positioning and Target Customers
Table Pfizer Production, Value ($), Price, Gross Margin 2012-2017E
Figure Pfizer Production and Growth Rate
Figure Pfizer Value ($) Market Share 2012-2017E
Figure Pfizer Market Share of Biologics And Biosimilars Segmented by Region in 2016
Table Company Profiles
Table Product Introduction
Table Market Positioning and Target Customers
Table Roche Production, Value ($), Price, Gross Margin 2012-2017E
Figure Roche Production and Growth Rate
Figure Roche Value ($) Market Share 2012-2017E
Figure Roche Market Share of Biologics And Biosimilars Segmented by Region in 2016
Table Company Profiles
Table Product Introduction
Table Market Positioning and Target Customers
Table Merck Production, Value ($), Price, Gross Margin 2012-2017E
Figure Merck Production and Growth Rate
Figure Merck Value ($) Market Share 2012-2017E
Figure Merck Market Share of Biologics And Biosimilars Segmented by Region in 2016
Table Company Profiles
Table Product Introduction
Table Market Positioning and Target Customers
Table 3sbio Production, Value ($), Price, Gross Margin 2012-2017E
Figure 3sbio Production and Growth Rate
Figure 3sbio Value ($) Market Share 2012-2017E
Figure 3sbio Market Share of Biologics And Biosimilars Segmented by Region in 2016
Table Company Profiles
Table Product Introduction
Table Market Positioning and Target Customers
Table Gelgen Production, Value ($), Price, Gross Margin 2012-2017E
Figure Gelgen Production and Growth Rate
Figure Gelgen Value ($) Market Share 2012-2017E
Figure Gelgen Market Share of Biologics And Biosimilars Segmented by Region in 2016
Table Global Biologics And Biosimilars Market Value ($) Forecast, by Type
Table Global Biologics And Biosimilars Market Volume Forecast, by Type
Figure Global Biologics And Biosimilars Market Value ($) and Growth Rate Forecast of Growth Factors (2017-2022)
Figure Global Biologics And Biosimilars Market Volume and Growth Rate Forecast of Growth Factors (2017-2022)
Figure Global Biologics And Biosimilars Market Value ($) and Growth Rate Forecast of Hormone (2017-2022)
Figure Global Biologics And Biosimilars Market Volume and Growth Rate Forecast of Hormone (2017-2022)
Figure Global Biologics And Biosimilars Market Value ($) and Growth Rate Forecast of Antibody (2017-2022)
Figure Global Biologics And Biosimilars Market Volume and Growth Rate Forecast of Antibody (2017-2022)
Table Global Market Value ($) Forecast by Application (2017-2022)
Table Global Market Volume Forecast by Application (2017-2022)
Figure Global Biologics And Biosimilars Consumption and Growth Rate of Cardiovascular (2012-2017)
Figure Global Biologics And Biosimilars Consumption and Growth Rate of Diabetes (2012-2017)
Figure Global Biologics And Biosimilars Consumption and Growth Rate of Tumor (2012-2017)
Figure Market Value ($) and Growth Rate Forecast of Tumor (2017-2022)
Figure Market Volume and Growth Rate Forecast of Tumor (2017-2022)
Figure North America Market Value ($) and Growth Rate Forecast (2017-2022)
Table North America Consumption and Growth Rate Forecast (2017-2022)
Figure Europe Market Value ($) and Growth Rate Forecast (2017-2022)
Table Europe Consumption and Growth Rate Forecast (2017-2022)
Figure China Market Value ($) and Growth Rate Forecast (2017-2022)
Table China Consumption and Growth Rate Forecast (2017-2022)
Figure Japan Market Value ($) and Growth Rate Forecast (2017-2022)
Table Japan Consumption and Growth Rate Forecast (2017-2022)
Figure Middle East & Africa Market Value ($) and Growth Rate Forecast (2017-2022)
Table Middle East & Africa Consumption and Growth Rate Forecast (2017-2022)
Figure India Market Value ($) and Growth Rate Forecast (2017-2022)
Table India Consumption and Growth Rate Forecast (2017-2022)
Figure South America Market Value ($) and Growth Rate Forecast (2017-2022)
Table South America Consumption and Growth Rate Forecast (2017-2022)
Figure Industry Resource/Technology/Labor Importance Analysis
Table New Entrants SWOT Analysis
Table New Project Analysis of Investment Recovery
Figure Product Picture of Biologics And Biosimilars
Table Product Specification of Biologics And Biosimilars
Figure Market Concentration Ratio and Market Maturity Analysis of Biologics And Biosimilars
Figure Global Biologics And Biosimilars Value ($) and Growth Rate from 2012-2022
Table Different Types of Biologics And Biosimilars
Figure Global Biologics And Biosimilars Value ($) Segment by Type from 2012-2017
Figure Growth Factors Picture
Figure Hormone Picture
Figure Antibody Picture
Table Different Applications of Biologics And Biosimilars
Figure Global Biologics And Biosimilars Value ($) Segment by Applications from 2012-2017
Figure Cardiovascular Picture
Figure Diabetes Picture
Figure Tumor Picture
Table Research Regions of Biologics And Biosimilars
Figure North America Biologics And Biosimilars Production Value ($) and Growth Rate (2012-2017)
Figure Europe Biologics And Biosimilars Production Value ($) and Growth Rate (2012-2017)
Table China Biologics And Biosimilars Production Value ($) and Growth Rate (2012-2017)
Table Japan Biologics And Biosimilars Production Value ($) and Growth Rate (2012-2017)
Table Middle East & Africa Biologics And Biosimilars Production Value ($) and Growth Rate (2012-2017)
Table India Biologics And Biosimilars Production Value ($) and Growth Rate (2012-2017)
Table South America Biologics And Biosimilars Production Value ($) and Growth Rate (2012-2017)
Table Emerging Countries of Biologics And Biosimilars
Table Growing Market of Biologics And Biosimilars
Figure Industry Chain Analysis of Biologics And Biosimilars
Table Upstream Raw Material Suppliers of Biologics And Biosimilars with Contact Information
Table Major Players Manufacturing Base and Market Share ($) of Biologics And Biosimilars in 2016
Table Major Players Biologics And Biosimilars Product Types in 2016
Figure Production Process of Biologics And Biosimilars
Figure Manufacturing Cost Structure of Biologics And Biosimilars
Figure Channel Status of Biologics And Biosimilars
Table Major Distributors of Biologics And Biosimilars with Contact Information
Table Major Downstream Buyers of Biologics And Biosimilars with Contact Information
Table Analysis of Market Status and Feature by Type
Table Global Biologics And Biosimilars Value ($) by Type (2012-2017)
Table Global Biologics And Biosimilars Value ($) Share by Type (2012-2017)
Figure Global Biologics And Biosimilars Value ($) Share by Type (2012-2017)
Table Global Biologics And Biosimilars Production by Type (2012-2017)
Table Global Biologics And Biosimilars Production Share by Type (2012-2017)
Figure Global Biologics And Biosimilars Production Share by Type (2012-2017)
Figure Global Biologics And Biosimilars Value ($) and Growth Rate of Growth Factors
Figure Global Biologics And Biosimilars Value ($) and Growth Rate of Hormone
Figure Global Biologics And Biosimilars Value ($) and Growth Rate of Antibody
Table Global Biologics And Biosimilars Price by Type (2012-2017)
Figure Downstream Market Overview
Table Global Biologics And Biosimilars Consumption by Application (2012-2017)
Table Global Biologics And Biosimilars Consumption Market Share by Application (2012-2017)
Figure Global Biologics And Biosimilars Consumption Market Share by Application (2012-2017)
Table Downstream Buyers Introduction by Application
Figure Global Biologics And Biosimilars Consumption and Growth Rate of Cardiovascular (2012-2017)
Figure Global Biologics And Biosimilars Consumption and Growth Rate of Diabetes (2012-2017)
Figure Global Biologics And Biosimilars Consumption and Growth Rate of Tumor (2012-2017)
Table Global Biologics And Biosimilars Value ($) by Region (2012-2017)
Table Global Biologics And Biosimilars Value ($) Market Share by Region (2012-2017)
Figure Global Biologics And Biosimilars Value ($) Market Share by Region (2012-2017)
Table Global Biologics And Biosimilars Production by Region (2012-2017)
Table Global Biologics And Biosimilars Production Market Share by Region (2012-2017)
Figure Global Biologics And Biosimilars Production Market Share by Region (2012-2017)
Table Global Biologics And Biosimilars Production, Value ($), Price and Gross Margin (2012-2017)
Table North America Biologics And Biosimilars Production, Value ($), Price and Gross Margin (2012-2017)
Table Europe Biologics And Biosimilars Production, Value ($), Price and Gross Margin (2012-2017)
Table China Biologics And Biosimilars Production, Value ($), Price and Gross Margin (2012-2017)
Table Japan Biologics And Biosimilars Production, Value ($), Price and Gross Margin (2012-2017)
Table Middle East & Africa Biologics And Biosimilars Production, Value ($), Price and Gross Margin (2012-2017)
Table India Biologics And Biosimilars Production, Value ($), Price and Gross Margin (2012-2017)
Table South America Biologics And Biosimilars Production, Value ($), Price and Gross Margin (2012-2017)
Table Global Biologics And Biosimilars Consumption by Regions (2012-2017)
Figure Global Biologics And Biosimilars Consumption Share by Regions (2012-2017)
Table North America Biologics And Biosimilars Production, Consumption, Export, Import (2012-2017)
Table Europe Biologics And Biosimilars Production, Consumption, Export, Import (2012-2017)
Table China Biologics And Biosimilars Production, Consumption, Export, Import (2012-2017)
Table Japan Biologics And Biosimilars Production, Consumption, Export, Import (2012-2017)
Table Middle East & Africa Biologics And Biosimilars Production, Consumption, Export, Import (2012-2017)
Table India Biologics And Biosimilars Production, Consumption, Export, Import (2012-2017)
Table South America Biologics And Biosimilars Production, Consumption, Export, Import (2012-2017)
Figure North America Biologics And Biosimilars Production and Growth Rate Analysis
Figure North America Biologics And Biosimilars Consumption and Growth Rate Analysis
Figure North America Biologics And Biosimilars SWOT Analysis
Figure Europe Biologics And Biosimilars Production and Growth Rate Analysis
Figure Europe Biologics And Biosimilars Consumption and Growth Rate Analysis
Figure Europe Biologics And Biosimilars SWOT Analysis
Figure China Biologics And Biosimilars Production and Growth Rate Analysis
Figure China Biologics And Biosimilars Consumption and Growth Rate Analysis
Figure China Biologics And Biosimilars SWOT Analysis
Figure Japan Biologics And Biosimilars Production and Growth Rate Analysis
Figure Japan Biologics And Biosimilars Consumption and Growth Rate Analysis
Figure Japan Biologics And Biosimilars SWOT Analysis
Figure Middle East & Africa Biologics And Biosimilars Production and Growth Rate Analysis
Figure Middle East & Africa Biologics And Biosimilars Consumption and Growth Rate Analysis
Figure Middle East & Africa Biologics And Biosimilars SWOT Analysis
Figure India Biologics And Biosimilars Production and Growth Rate Analysis
Figure India Biologics And Biosimilars Consumption and Growth Rate Analysis
Figure India Biologics And Biosimilars SWOT Analysis
Figure South America Biologics And Biosimilars Production and Growth Rate Analysis
Figure South America Biologics And Biosimilars Consumption and Growth Rate Analysis
Figure South America Biologics And Biosimilars SWOT Analysis
Figure Competitive Matrix and Pattern Characteristics of Biologics And Biosimilars Market
Figure Top 3 Market Share of Biologics And Biosimilars Companies
Figure Top 6 Market Share of Biologics And Biosimilars Companies
Table Mergers, Acquisitions and Expansion Analysis
Table Company Profiles
Table Product Introduction
Table Market Positioning and Target Customers
Table Novo Nordisk Production, Value ($), Price, Gross Margin 2012-2017E
Figure Novo Nordisk Production and Growth Rate
Figure Novo Nordisk Value ($) Market Share 2012-2017E
Figure Novo Nordisk Market Share of Biologics And Biosimilars Segmented by Region in 2016
Table Company Profiles
Table Product Introduction
Table Market Positioning and Target Customers
Table Johnson & Johnson Production, Value ($), Price, Gross Margin 2012-2017E
Figure Johnson & Johnson Production and Growth Rate
Figure Johnson & Johnson Value ($) Market Share 2012-2017E
Figure Johnson & Johnson Market Share of Biologics And Biosimilars Segmented by Region in 2016
Table Company Profiles
Table Product Introduction
Table Market Positioning and Target Customers
Table Amgen Production, Value ($), Price, Gross Margin 2012-2017E
Figure Amgen Production and Growth Rate
Figure Amgen Value ($) Market Share 2012-2017E
Figure Amgen Market Share of Biologics And Biosimilars Segmented by Region in 2016
Table Company Profiles
Table Product Introduction
Table Market Positioning and Target Customers
Table AbbVie Production, Value ($), Price, Gross Margin 2012-2017E
Figure AbbVie Production and Growth Rate
Figure AbbVie Value ($) Market Share 2012-2017E
Figure AbbVie Market Share of Biologics And Biosimilars Segmented by Region in 2016
Table Company Profiles
Table Product Introduction
Table Market Positioning and Target Customers
Table Eli Lilly Production, Value ($), Price, Gross Margin 2012-2017E
Figure Eli Lilly Production and Growth Rate
Figure Eli Lilly Value ($) Market Share 2012-2017E
Figure Eli Lilly Market Share of Biologics And Biosimilars Segmented by Region in 2016
Table Company Profiles
Table Product Introduction
Table Market Positioning and Target Customers
Table United Laboratories Production, Value ($), Price, Gross Margin 2012-2017E
Figure United Laboratories Production and Growth Rate
Figure United Laboratories Value ($) Market Share 2012-2017E
Figure United Laboratories Market Share of Biologics And Biosimilars Segmented by Region in 2016
Table Company Profiles
Table Product Introduction
Table Market Positioning and Target Customers
Table Ganlee Production, Value ($), Price, Gross Margin 2012-2017E
Figure Ganlee Production and Growth Rate
Figure Ganlee Value ($) Market Share 2012-2017E
Figure Ganlee Market Share of Biologics And Biosimilars Segmented by Region in 2016
Table Company Profiles
Table Product Introduction
Table Market Positioning and Target Customers
Table Innovent Production, Value ($), Price, Gross Margin 2012-2017E
Figure Innovent Production and Growth Rate
Figure Innovent Value ($) Market Share 2012-2017E
Figure Innovent Market Share of Biologics And Biosimilars Segmented by Region in 2016
Table Company Profiles
Table Product Introduction
Table Market Positioning and Target Customers
Table Novartis Production, Value ($), Price, Gross Margin 2012-2017E
Figure Novartis Production and Growth Rate
Figure Novartis Value ($) Market Share 2012-2017E
Figure Novartis Market Share of Biologics And Biosimilars Segmented by Region in 2016
Table Company Profiles
Table Product Introduction
Table Market Positioning and Target Customers
Table Biotech Production, Value ($), Price, Gross Margin 2012-2017E
Figure Biotech Production and Growth Rate
Figure Biotech Value ($) Market Share 2012-2017E
Figure Biotech Market Share of Biologics And Biosimilars Segmented by Region in 2016
Table Company Profiles
Table Product Introduction
Table Market Positioning and Target Customers
Table CP Guojian Production, Value ($), Price, Gross Margin 2012-2017E
Figure CP Guojian Production and Growth Rate
Figure CP Guojian Value ($) Market Share 2012-2017E
Figure CP Guojian Market Share of Biologics And Biosimilars Segmented by Region in 2016
Table Company Profiles
Table Product Introduction
Table Market Positioning and Target Customers
Table Dong Bao Production, Value ($), Price, Gross Margin 2012-2017E
Figure Dong Bao Production and Growth Rate
Figure Dong Bao Value ($) Market Share 2012-2017E
Figure Dong Bao Market Share of Biologics And Biosimilars Segmented by Region in 2016
Table Company Profiles
Table Product Introduction
Table Market Positioning and Target Customers
Table Changchun High Tech Production, Value ($), Price, Gross Margin 2012-2017E
Figure Changchun High Tech Production and Growth Rate
Figure Changchun High Tech Value ($) Market Share 2012-2017E
Figure Changchun High Tech Market Share of Biologics And Biosimilars Segmented by Region in 2016
Table Company Profiles
Table Product Introduction
Table Market Positioning and Target Customers
Table Sanofi-Aventis Production, Value ($), Price, Gross Margin 2012-2017E
Figure Sanofi-Aventis Production and Growth Rate
Figure Sanofi-Aventis Value ($) Market Share 2012-2017E
Figure Sanofi-Aventis Market Share of Biologics And Biosimilars Segmented by Region in 2016
Table Company Profiles
Table Product Introduction
Table Market Positioning and Target Customers
Table Pfizer Production, Value ($), Price, Gross Margin 2012-2017E
Figure Pfizer Production and Growth Rate
Figure Pfizer Value ($) Market Share 2012-2017E
Figure Pfizer Market Share of Biologics And Biosimilars Segmented by Region in 2016
Table Company Profiles
Table Product Introduction
Table Market Positioning and Target Customers
Table Roche Production, Value ($), Price, Gross Margin 2012-2017E
Figure Roche Production and Growth Rate
Figure Roche Value ($) Market Share 2012-2017E
Figure Roche Market Share of Biologics And Biosimilars Segmented by Region in 2016
Table Company Profiles
Table Product Introduction
Table Market Positioning and Target Customers
Table Merck Production, Value ($), Price, Gross Margin 2012-2017E
Figure Merck Production and Growth Rate
Figure Merck Value ($) Market Share 2012-2017E
Figure Merck Market Share of Biologics And Biosimilars Segmented by Region in 2016
Table Company Profiles
Table Product Introduction
Table Market Positioning and Target Customers
Table 3sbio Production, Value ($), Price, Gross Margin 2012-2017E
Figure 3sbio Production and Growth Rate
Figure 3sbio Value ($) Market Share 2012-2017E
Figure 3sbio Market Share of Biologics And Biosimilars Segmented by Region in 2016
Table Company Profiles
Table Product Introduction
Table Market Positioning and Target Customers
Table Gelgen Production, Value ($), Price, Gross Margin 2012-2017E
Figure Gelgen Production and Growth Rate
Figure Gelgen Value ($) Market Share 2012-2017E
Figure Gelgen Market Share of Biologics And Biosimilars Segmented by Region in 2016
Table Global Biologics And Biosimilars Market Value ($) Forecast, by Type
Table Global Biologics And Biosimilars Market Volume Forecast, by Type
Figure Global Biologics And Biosimilars Market Value ($) and Growth Rate Forecast of Growth Factors (2017-2022)
Figure Global Biologics And Biosimilars Market Volume and Growth Rate Forecast of Growth Factors (2017-2022)
Figure Global Biologics And Biosimilars Market Value ($) and Growth Rate Forecast of Hormone (2017-2022)
Figure Global Biologics And Biosimilars Market Volume and Growth Rate Forecast of Hormone (2017-2022)
Figure Global Biologics And Biosimilars Market Value ($) and Growth Rate Forecast of Antibody (2017-2022)
Figure Global Biologics And Biosimilars Market Volume and Growth Rate Forecast of Antibody (2017-2022)
Table Global Market Value ($) Forecast by Application (2017-2022)
Table Global Market Volume Forecast by Application (2017-2022)
Figure Global Biologics And Biosimilars Consumption and Growth Rate of Cardiovascular (2012-2017)
Figure Global Biologics And Biosimilars Consumption and Growth Rate of Diabetes (2012-2017)
Figure Global Biologics And Biosimilars Consumption and Growth Rate of Tumor (2012-2017)
Figure Market Value ($) and Growth Rate Forecast of Tumor (2017-2022)
Figure Market Volume and Growth Rate Forecast of Tumor (2017-2022)
Figure North America Market Value ($) and Growth Rate Forecast (2017-2022)
Table North America Consumption and Growth Rate Forecast (2017-2022)
Figure Europe Market Value ($) and Growth Rate Forecast (2017-2022)
Table Europe Consumption and Growth Rate Forecast (2017-2022)
Figure China Market Value ($) and Growth Rate Forecast (2017-2022)
Table China Consumption and Growth Rate Forecast (2017-2022)
Figure Japan Market Value ($) and Growth Rate Forecast (2017-2022)
Table Japan Consumption and Growth Rate Forecast (2017-2022)
Figure Middle East & Africa Market Value ($) and Growth Rate Forecast (2017-2022)
Table Middle East & Africa Consumption and Growth Rate Forecast (2017-2022)
Figure India Market Value ($) and Growth Rate Forecast (2017-2022)
Table India Consumption and Growth Rate Forecast (2017-2022)
Figure South America Market Value ($) and Growth Rate Forecast (2017-2022)
Table South America Consumption and Growth Rate Forecast (2017-2022)
Figure Industry Resource/Technology/Labor Importance Analysis
Table New Entrants SWOT Analysis
Table New Project Analysis of Investment Recovery
